[1] |
LI Lei, LIU Xiaodan, ZHOU Kaixiang, HE Linjie, ZHANG Jian, CHEN Qiang, MENG Han, FENG Huan, ZHANG Wenming, LU Jun, ZHOU Feng, CUI Hongzun, NIU Wancheng, ZHANG Zhaohui.
Effects of ischemia postconditioning on mitochondrial function in rats and its protective mechanisms in hepatic ischemia-reperfusion injury
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 48-54.
|
[2] |
CHEN Xiaodan, ZHOU Shu, LYU Yanru, XU Zhiyong, LAN Haiyan, LU Shui, GAO Shan, SHU Liuyang, LIN Siyang, HAO Yanrong, XIE Yanyan.
Study on the initial titration dose and genetic polymorphism of oxycodone hydrochloride prolonged-release tablets in the treatment of severe cancer pain
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 74-80.
|
[3] |
PAN Hongxin, CUI Wangfei, LYU Licheng, WANG Xinzheng, CAO Ling, ZHANG Yongzhen.
Analysis of the incidence and mortality of malignant tumors in tumor registration areas of Shanxi Province,2020
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 700-706.
|
[4] |
AN Yanxiao, JIAO Hanliang, QI Yanwei, ZHONG Zhiyong.
Effects of lncRNA PSMA3-AS1 on proliferation,migration and invasion of neuroblastoma cells by regulating the miR-186?5p/SOX4 axis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 715-721.
|
[5] |
JIANG Yuan, WANG Xiaoyan, LEI lei, LIU Lihua, WU Danfeng, ZHANG Siqi, TANG Dairong, FAN Lingli, FENG Gang, XUE Xiaojing.
Summary of the best evidence for blood glucose management in cancer patients with immune checkpoint inhibitors inducing hyperglycemia
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 722-728.
|
[6] |
HUANG Shihuan, LAN Huiyu, NONG Xiaolian, LI Fanrong, ZHAO Fengjuan, YOU Xuemei.
Network analysis of concurrent symptoms and core symptom identification in patients with intermediate and advanced hepatocellular carcinoma after surgery
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 729-735.
|
[7] |
LYU Liwei, CONG Jia, WU Yiping, WANG Liang .
BCMA CAR-T cell therapy for relapsed/refractory plasmablastic lymphoma: case report and clinical implication
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 562-565.
|
[8] |
LIANG Yuanzheng, WANG Henan, WANG Liang.
Effects of PPP2R5C on proliferation, apoptosis, and drug sensitivity of multiple myeloma cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 405-411.
|
[9] |
ZHOU Da, WANG Mingyue, LI Zhe, HE Qing, CEN Hong.
Single-center clinical experience of daratumumab combined with bendamustine in the treatment of multiple myeloma patients with secondary extramedullary disease
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 412-416.
|
[10] |
TANG Min, HUANG Juanchan, WEI Xingwen, LUO Xuewen, ZHAO Wei .
Effects of disulfiram combined with Cu2+ induced cuproptosis on proli-feration,migration and invasion of hepatoma Hep3B cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 417-423.
|
[11] |
LI Tingting, LIU Yan .
Comparison of the separation and purification methods of small extracellular vesicles in mesenchymal stem cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 424-432.
|
[12] |
SU Xin, FAN Wenyi, XU Xinye, XU Xuedong.
Analysis of risk factors and attributable disease burden of four major chronic diseases including cancer in the Chinese population
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 442-447.
|
[13] |
ZHANG Siyi, HUANG Xiangyang, QIN Yunying, LIU Lijuan, HUANG Caiyun, LUO Ningbin.
Preoperative CT signs combined with clinical indicators predict the expression of cytokeratin 19 in hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 461-467.
|
[14] |
WU Yan, JIANG Honghong, YANG Yongxiang, CHEN Jie.
Longitudinal association between symptom clusters and quality of life in perioperative rectal cancer patients: a network-based analysis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 474-480.
|
[15] |
LI Shuimei, XU Sujuan, YIN Hai, ZHONG Yanmei, LIU Yingying, LIANG Jingyan.
Machine learning-based analysis of risk factors for postoperative facial paralysis in patients with parotid tumors
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 481-486.
|